pubmed-article:12239583 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:12239583 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
pubmed-article:12239583 | lifeskim:mentions | umls-concept:C0162638 | lld:lifeskim |
pubmed-article:12239583 | lifeskim:mentions | umls-concept:C2323499 | lld:lifeskim |
pubmed-article:12239583 | lifeskim:mentions | umls-concept:C0085732 | lld:lifeskim |
pubmed-article:12239583 | lifeskim:mentions | umls-concept:C2349975 | lld:lifeskim |
pubmed-article:12239583 | lifeskim:mentions | umls-concept:C0969590 | lld:lifeskim |
pubmed-article:12239583 | pubmed:issue | 4 | lld:pubmed |
pubmed-article:12239583 | pubmed:dateCreated | 2002-9-19 | lld:pubmed |
pubmed-article:12239583 | pubmed:abstractText | Repopulating hematopoietic cell compartments after myeloablative chemotherapy remains a key factor in a successful chemotherapy program. Modified and chimeric cytokines have been developed to help reduce inflammation, fever and hospitalization time for patients. A chimeric cytokine, progenipoietin-1 (ProGP-1), containing the G-CSF and FL receptor agonists binds both the G-CSF receptor and FLT-3. It also stimulates the growth of dendritic cells, which play an important role in immunotherapy. While in vivo effects of ProGP-1 are well described, the mechanisms by which it stimulates growth are not well understood. We have investigated the effects of ProGP-1 on prevention of apoptosis in the human hematopoietic cell line OCI-AML.5. ProGP-1 promoted cellular proliferation better than G-CSF or FL separately but stimulated proliferation similar to their co-addition as demonstrated by growth curves and [3H]-thymidine incorporation. ProGP-1 prevented apoptosis to a greater degree than G-CSF or FL alone as determined by annexin V/propidium iodide binding and TUNEL assays. ProGP-1 promoted maintenance of the mitochondrial membrane potential better than G-CSF or FL alone. In addition, Pro-GP promoted a lower redox potential as higher levels of free radicals were detected after cytokine treatment than in cytokine-deprived cells implying increased respiration. These data indicate that ProGP-1 promotes the proliferation and prevents the apoptosis of human hematopoietic cells better than FL or G-CSF alone, and to a similar extent as their co-addition. Thus, ProGP-1 can be used to repopulate certain hematopoietic cells as a single entity rather than the introduction of two different cytokines. | lld:pubmed |
pubmed-article:12239583 | pubmed:language | eng | lld:pubmed |
pubmed-article:12239583 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12239583 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:12239583 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12239583 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12239583 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12239583 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12239583 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12239583 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12239583 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12239583 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12239583 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:12239583 | pubmed:month | Oct | lld:pubmed |
pubmed-article:12239583 | pubmed:issn | 1107-3756 | lld:pubmed |
pubmed-article:12239583 | pubmed:author | pubmed-author:McCubreyJames... | lld:pubmed |
pubmed-article:12239583 | pubmed:author | pubmed-author:SalehOussama... | lld:pubmed |
pubmed-article:12239583 | pubmed:author | pubmed-author:BlalockWillia... | lld:pubmed |
pubmed-article:12239583 | pubmed:author | pubmed-author:BurrowsCarlaC | lld:pubmed |
pubmed-article:12239583 | pubmed:author | pubmed-author:SteelmanLinda... | lld:pubmed |
pubmed-article:12239583 | pubmed:author | pubmed-author:DoshiParul... | lld:pubmed |
pubmed-article:12239583 | pubmed:author | pubmed-author:McKearnJohn... | lld:pubmed |
pubmed-article:12239583 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:12239583 | pubmed:volume | 10 | lld:pubmed |
pubmed-article:12239583 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:12239583 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:12239583 | pubmed:pagination | 385-94 | lld:pubmed |
pubmed-article:12239583 | pubmed:dateRevised | 2005-11-17 | lld:pubmed |
pubmed-article:12239583 | pubmed:meshHeading | pubmed-meshheading:12239583... | lld:pubmed |
pubmed-article:12239583 | pubmed:meshHeading | pubmed-meshheading:12239583... | lld:pubmed |
pubmed-article:12239583 | pubmed:meshHeading | pubmed-meshheading:12239583... | lld:pubmed |
pubmed-article:12239583 | pubmed:meshHeading | pubmed-meshheading:12239583... | lld:pubmed |
pubmed-article:12239583 | pubmed:meshHeading | pubmed-meshheading:12239583... | lld:pubmed |
pubmed-article:12239583 | pubmed:meshHeading | pubmed-meshheading:12239583... | lld:pubmed |
pubmed-article:12239583 | pubmed:meshHeading | pubmed-meshheading:12239583... | lld:pubmed |
pubmed-article:12239583 | pubmed:meshHeading | pubmed-meshheading:12239583... | lld:pubmed |
pubmed-article:12239583 | pubmed:meshHeading | pubmed-meshheading:12239583... | lld:pubmed |
pubmed-article:12239583 | pubmed:meshHeading | pubmed-meshheading:12239583... | lld:pubmed |
pubmed-article:12239583 | pubmed:meshHeading | pubmed-meshheading:12239583... | lld:pubmed |
pubmed-article:12239583 | pubmed:meshHeading | pubmed-meshheading:12239583... | lld:pubmed |
pubmed-article:12239583 | pubmed:meshHeading | pubmed-meshheading:12239583... | lld:pubmed |
pubmed-article:12239583 | pubmed:year | 2002 | lld:pubmed |
pubmed-article:12239583 | pubmed:articleTitle | Enhanced ability of the progenipoietin-1 to suppress apoptosis in human hematopoietic cells. | lld:pubmed |
pubmed-article:12239583 | pubmed:affiliation | Department of Microbiology and Immunology, Brody School of Medicine at East Carolina University, Greenville, NC 27858, USA. | lld:pubmed |
pubmed-article:12239583 | pubmed:publicationType | Journal Article | lld:pubmed |